{"transactions":[{"id":729232,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2026-06-23T20:31:21.000Z","date":"2026-06-18","kind":"exercise","planned":false,"acquired":false,"shares":3576,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The entire award vested or vests on the earlier of the: (i) date of the 2026 annual meeting of the Issuer's stockholders, or (ii) first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the vesting date.  These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The entire award vested or vests on the earlier of the: (i) date of the 2026 annual meeting of the Issuer's stockholders, or (ii) first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the vesting date.  These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":3576},"source":{"system":"sec-edgar","filing":"0001585017-26-000002","document":"form4-06232026_080617.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000158501726000002/form4-06232026_080617.xml","form_type":"4"}},{"id":729231,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-06-23T20:31:21.000Z","date":"2026-06-18","kind":"exercise","planned":false,"acquired":true,"shares":3576,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."}],"balance_after":15480,"source":{"system":"sec-edgar","filing":"0001585017-26-000002","document":"form4-06232026_080617.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000158501726000002/form4-06232026_080617.xml","form_type":"4"}},{"id":1054638,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-08-28T01:01:50.000Z","date":"2025-08-27","kind":"sale","planned":false,"acquired":false,"shares":1150,"price":129.6461,"value":149093.015,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $129.50 to $129.76 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":11904,"source":{"system":"sec-edgar","filing":"0001415889-25-023190","document":"form4-08282025_010846.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000141588925023190/form4-08282025_010846.xml","form_type":"4"}},{"id":1054637,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-08-28T01:01:50.000Z","date":"2025-08-27","kind":"sale","planned":false,"acquired":false,"shares":1500,"price":130.0103,"value":195015.45,"ownership":{"direct":false,"nature":"By Jason Ryan 2024 GRAT"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $129.91 to $130.19 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reporting person is the trustee of the Jason Ryan 2024 GRAT Trust U/A DTD 11/7/2024 (the \"GRAT\"), and the reporting person is the sole annuitant of the GRAT. The reporting person remains the beneficial owner of the securities held by the GRAT."}],"balance_after":103284,"source":{"system":"sec-edgar","filing":"0001415889-25-023190","document":"form4-08282025_010846.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000141588925023190/form4-08282025_010846.xml","form_type":"4"}},{"id":1054636,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-08-28T01:01:50.000Z","date":"2025-08-27","kind":"sale","planned":false,"acquired":false,"shares":9890,"price":129.5945,"value":1281689.605,"ownership":{"direct":false,"nature":"By Jason Ryan 2024 GRAT"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $128.89 to $129.88 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reporting person is the trustee of the Jason Ryan 2024 GRAT Trust U/A DTD 11/7/2024 (the \"GRAT\"), and the reporting person is the sole annuitant of the GRAT. The reporting person remains the beneficial owner of the securities held by the GRAT."}],"balance_after":104784,"source":{"system":"sec-edgar","filing":"0001415889-25-023190","document":"form4-08282025_010846.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000141588925023190/form4-08282025_010846.xml","form_type":"4"}},{"id":1054635,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-08-28T01:01:50.000Z","date":"2025-08-27","kind":"sale","planned":false,"acquired":false,"shares":3452,"price":128.0408,"value":441996.8416,"ownership":{"direct":false,"nature":"By Jason Ryan 2024 GRAT"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $127.76 to $128.75 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reporting person is the trustee of the Jason Ryan 2024 GRAT Trust U/A DTD 11/7/2024 (the \"GRAT\"), and the reporting person is the sole annuitant of the GRAT. The reporting person remains the beneficial owner of the securities held by the GRAT."}],"balance_after":114674,"source":{"system":"sec-edgar","filing":"0001415889-25-023190","document":"form4-08282025_010846.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000141588925023190/form4-08282025_010846.xml","form_type":"4"}},{"id":1054634,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-08-28T01:01:50.000Z","date":"2025-08-27","kind":"sale","planned":false,"acquired":false,"shares":5443,"price":127.4373,"value":693641.2239,"ownership":{"direct":false,"nature":"By Jason Ryan 2024 GRAT"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.76 to $127.75 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reporting person is the trustee of the Jason Ryan 2024 GRAT Trust U/A DTD 11/7/2024 (the \"GRAT\"), and the reporting person is the sole annuitant of the GRAT. The reporting person remains the beneficial owner of the securities held by the GRAT."}],"balance_after":118126,"source":{"system":"sec-edgar","filing":"0001415889-25-023190","document":"form4-08282025_010846.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000141588925023190/form4-08282025_010846.xml","form_type":"4"}},{"id":1054633,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-08-28T01:01:50.000Z","date":"2025-08-27","kind":"sale","planned":false,"acquired":false,"shares":8969,"price":126.1536,"value":1131471.6384,"ownership":{"direct":false,"nature":"By Jason Ryan 2024 GRAT"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $125.655 to $126.62 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reporting person is the trustee of the Jason Ryan 2024 GRAT Trust U/A DTD 11/7/2024 (the \"GRAT\"), and the reporting person is the sole annuitant of the GRAT. The reporting person remains the beneficial owner of the securities held by the GRAT."}],"balance_after":123569,"source":{"system":"sec-edgar","filing":"0001415889-25-023190","document":"form4-08282025_010846.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000141588925023190/form4-08282025_010846.xml","form_type":"4"}},{"id":1054632,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-08-28T01:01:50.000Z","date":"2025-08-27","kind":"sale","planned":false,"acquired":false,"shares":8818,"price":125.0729,"value":1102892.8322,"ownership":{"direct":false,"nature":"By Jason Ryan 2024 GRAT"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.50 to $125.44 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reporting person is the trustee of the Jason Ryan 2024 GRAT Trust U/A DTD 11/7/2024 (the \"GRAT\"), and the reporting person is the sole annuitant of the GRAT. The reporting person remains the beneficial owner of the securities held by the GRAT."}],"balance_after":132538,"source":{"system":"sec-edgar","filing":"0001415889-25-023190","document":"form4-08282025_010846.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000141588925023190/form4-08282025_010846.xml","form_type":"4"}},{"id":1103902,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2025-06-23T21:48:46.000Z","date":"2025-06-18","kind":"exercise","planned":false,"acquired":false,"shares":12924,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs shall vest the earlier of (a) the date of the next annual meeting of the Issuer's shareholders following the grant date, and (b) the first anniversary of the grant date, subject to the Reporting Person continuing to provide services to the Issuer through each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs shall vest the earlier of (a) the date of the next annual meeting of the Issuer's shareholders following the grant date, and (b) the first anniversary of the grant date, subject to the Reporting Person continuing to provide services to the Issuer through each vesting date."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":12924},"source":{"system":"sec-edgar","filing":"0001415889-25-017990","document":"form4-06232025_090642.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000141588925017990/form4-06232025_090642.xml","form_type":"4"}},{"id":1103901,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2025-06-23T21:48:46.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":3576,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs shall vest the earlier of (a) the date of the next annual meeting of the Issuer's shareholders following the grant date, and (b) the first anniversary of the grant date, subject to the Reporting Person continuing to provide services to the Issuer through each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs shall vest the earlier of (a) the date of the next annual meeting of the Issuer's shareholders following the grant date, and (b) the first anniversary of the grant date, subject to the Reporting Person continuing to provide services to the Issuer through each vesting date."}],"balance_after":3576,"derivative":{"underlying":"Class A Common Stock","underlying_shares":3576},"source":{"system":"sec-edgar","filing":"0001415889-25-017990","document":"form4-06232025_090642.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000141588925017990/form4-06232025_090642.xml","form_type":"4"}},{"id":1103900,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-06-23T21:48:46.000Z","date":"2025-06-18","kind":"exercise","planned":false,"acquired":true,"shares":12924,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."}],"balance_after":13054,"source":{"system":"sec-edgar","filing":"0001415889-25-017990","document":"form4-06232025_090642.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000141588925017990/form4-06232025_090642.xml","form_type":"4"}},{"id":1246532,"issuer":{"id":82741,"kind":"organization","name":"Singular Genomics Systems, Inc.","symbol":"OMIC"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-25T20:08:25.000Z","date":"2025-02-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2466,"price":8.84,"value":21799.44,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of December 22, 2024 (the \"Merger Agreement\"), by and among the Issuer, Singular Genomics Parent, LLC, a Delaware limited liability company, and Saturn Merger Sub, Inc., a Delaware corporation, and after giving effect to the acceleration treatment set forth in footnote (2), each vested stock option was cancelled and automatically converted into the right to receive an amount in cash determined by multiplying (x) the excess, if any, of the amount of $20.00 per share over the applicable exercise price of such option by (y) the number of vested shares subject to such option (the \"Option Payment\"), less all applicable deductions and withholdings; provided, however, that the Option Payment for each option with an exercise price equal to or greater than $20.00 was $0 and such option was cancelled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of December 22, 2024 (the \"Merger Agreement\"), by and among the Issuer, Singular Genomics Parent, LLC, a Delaware limited liability company, and Saturn Merger Sub, Inc., a Delaware corporation, and after giving effect to the acceleration treatment set forth in footnote (2), each vested stock option was cancelled and automatically converted into the right to receive an amount in cash determined by multiplying (x) the excess, if any, of the amount of $20.00 per share over the applicable exercise price of such option by (y) the number of vested shares subject to such option (the \"Option Payment\"), less all applicable deductions and withholdings; provided, however, that the Option Payment for each option with an exercise price equal to or greater than $20.00 was $0 and such option was cancelled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"As of the effective time of the merger contemplated within the Merger Agreement, each outstanding option, to the extent unvested, was accelerated and became fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":11.16,"expiration_date":"2034-05-29","underlying":"Common Stock","underlying_shares":2466},"source":{"system":"sec-edgar","filing":"0000950170-25-027101","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1850906/000095017025027101/ownership.xml","form_type":"4"}},{"id":1246531,"issuer":{"id":82741,"kind":"organization","name":"Singular Genomics Systems, Inc.","symbol":"OMIC"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-25T20:08:25.000Z","date":"2025-02-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2466,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of December 22, 2024 (the \"Merger Agreement\"), by and among the Issuer, Singular Genomics Parent, LLC, a Delaware limited liability company, and Saturn Merger Sub, Inc., a Delaware corporation, and after giving effect to the acceleration treatment set forth in footnote (2), each vested stock option was cancelled and automatically converted into the right to receive an amount in cash determined by multiplying (x) the excess, if any, of the amount of $20.00 per share over the applicable exercise price of such option by (y) the number of vested shares subject to such option (the \"Option Payment\"), less all applicable deductions and withholdings; provided, however, that the Option Payment for each option with an exercise price equal to or greater than $20.00 was $0 and such option was cancelled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of December 22, 2024 (the \"Merger Agreement\"), by and among the Issuer, Singular Genomics Parent, LLC, a Delaware limited liability company, and Saturn Merger Sub, Inc., a Delaware corporation, and after giving effect to the acceleration treatment set forth in footnote (2), each vested stock option was cancelled and automatically converted into the right to receive an amount in cash determined by multiplying (x) the excess, if any, of the amount of $20.00 per share over the applicable exercise price of such option by (y) the number of vested shares subject to such option (the \"Option Payment\"), less all applicable deductions and withholdings; provided, however, that the Option Payment for each option with an exercise price equal to or greater than $20.00 was $0 and such option was cancelled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"As of the effective time of the merger contemplated within the Merger Agreement, each outstanding option, to the extent unvested, was accelerated and became fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":31.8,"expiration_date":"2033-05-25","underlying":"Common Stock","underlying_shares":2466},"source":{"system":"sec-edgar","filing":"0000950170-25-027101","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1850906/000095017025027101/ownership.xml","form_type":"4"}},{"id":1246530,"issuer":{"id":82741,"kind":"organization","name":"Singular Genomics Systems, Inc.","symbol":"OMIC"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-25T20:08:25.000Z","date":"2025-02-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1541,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of December 22, 2024 (the \"Merger Agreement\"), by and among the Issuer, Singular Genomics Parent, LLC, a Delaware limited liability company, and Saturn Merger Sub, Inc., a Delaware corporation, and after giving effect to the acceleration treatment set forth in footnote (2), each vested stock option was cancelled and automatically converted into the right to receive an amount in cash determined by multiplying (x) the excess, if any, of the amount of $20.00 per share over the applicable exercise price of such option by (y) the number of vested shares subject to such option (the \"Option Payment\"), less all applicable deductions and withholdings; provided, however, that the Option Payment for each option with an exercise price equal to or greater than $20.00 was $0 and such option was cancelled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of December 22, 2024 (the \"Merger Agreement\"), by and among the Issuer, Singular Genomics Parent, LLC, a Delaware limited liability company, and Saturn Merger Sub, Inc., a Delaware corporation, and after giving effect to the acceleration treatment set forth in footnote (2), each vested stock option was cancelled and automatically converted into the right to receive an amount in cash determined by multiplying (x) the excess, if any, of the amount of $20.00 per share over the applicable exercise price of such option by (y) the number of vested shares subject to such option (the \"Option Payment\"), less all applicable deductions and withholdings; provided, however, that the Option Payment for each option with an exercise price equal to or greater than $20.00 was $0 and such option was cancelled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"As of the effective time of the merger contemplated within the Merger Agreement, each outstanding option, to the extent unvested, was accelerated and became fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":85.8,"expiration_date":"2032-05-26","underlying":"Common Stock","underlying_shares":1541},"source":{"system":"sec-edgar","filing":"0000950170-25-027101","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1850906/000095017025027101/ownership.xml","form_type":"4"}},{"id":1246529,"issuer":{"id":82741,"kind":"organization","name":"Singular Genomics Systems, Inc.","symbol":"OMIC"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-25T20:08:25.000Z","date":"2025-02-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of December 22, 2024 (the \"Merger Agreement\"), by and among the Issuer, Singular Genomics Parent, LLC, a Delaware limited liability company, and Saturn Merger Sub, Inc., a Delaware corporation, and after giving effect to the acceleration treatment set forth in footnote (2), each vested stock option was cancelled and automatically converted into the right to receive an amount in cash determined by multiplying (x) the excess, if any, of the amount of $20.00 per share over the applicable exercise price of such option by (y) the number of vested shares subject to such option (the \"Option Payment\"), less all applicable deductions and withholdings; provided, however, that the Option Payment for each option with an exercise price equal to or greater than $20.00 was $0 and such option was cancelled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of December 22, 2024 (the \"Merger Agreement\"), by and among the Issuer, Singular Genomics Parent, LLC, a Delaware limited liability company, and Saturn Merger Sub, Inc., a Delaware corporation, and after giving effect to the acceleration treatment set forth in footnote (2), each vested stock option was cancelled and automatically converted into the right to receive an amount in cash determined by multiplying (x) the excess, if any, of the amount of $20.00 per share over the applicable exercise price of such option by (y) the number of vested shares subject to such option (the \"Option Payment\"), less all applicable deductions and withholdings; provided, however, that the Option Payment for each option with an exercise price equal to or greater than $20.00 was $0 and such option was cancelled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"As of the effective time of the merger contemplated within the Merger Agreement, each outstanding option, to the extent unvested, was accelerated and became fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":672.9,"expiration_date":"2031-05-05","underlying":"Common Stock","underlying_shares":1333},"source":{"system":"sec-edgar","filing":"0000950170-25-027101","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850906/000095017025027101/ownership.xml","form_type":"4"}},{"id":1355859,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2024-11-22T01:21:28.000Z","date":"2024-11-20","kind":"sale","planned":false,"acquired":false,"shares":4272,"price":70.502,"value":301184.544,"ownership":{"direct":false,"nature":"By Jason Ryan u/a dtd 11/25/2018"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.22 to $70.96 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-24-027473","document":"form4-11222024_011124.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000141588924027473/form4-11222024_011124.xml","form_type":"4"}},{"id":1355858,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2024-11-22T01:21:28.000Z","date":"2024-11-20","kind":"sale","planned":false,"acquired":false,"shares":1857,"price":69.8379,"value":129688.9803,"ownership":{"direct":false,"nature":"By Jason Ryan Trust u/a dtd 11/25/2018"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.22 to $70.21 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":4272,"source":{"system":"sec-edgar","filing":"0001415889-24-027473","document":"form4-11222024_011124.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000141588924027473/form4-11222024_011124.xml","form_type":"4"}},{"id":1355857,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2024-11-22T01:21:28.000Z","date":"2024-11-20","kind":"sale","planned":false,"acquired":false,"shares":9361,"price":68.3555,"value":639875.8355,"ownership":{"direct":false,"nature":"By Jason Ryan Trust u/a dtd 11/25/2018"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.01 to $68.89 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":6129,"source":{"system":"sec-edgar","filing":"0001415889-24-027473","document":"form4-11222024_011124.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000141588924027473/form4-11222024_011124.xml","form_type":"4"}},{"id":1355856,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2024-11-22T01:21:28.000Z","date":"2024-11-19","kind":"sale","planned":false,"acquired":false,"shares":774,"price":72.2565,"value":55926.531,"ownership":{"direct":false,"nature":"By Jason Ryan Trust u/a dtd 11/25/2018"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.12 to $72.49 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":15490,"source":{"system":"sec-edgar","filing":"0001415889-24-027473","document":"form4-11222024_011124.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000141588924027473/form4-11222024_011124.xml","form_type":"4"}},{"id":1355855,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2024-11-22T01:21:28.000Z","date":"2024-11-19","kind":"sale","planned":false,"acquired":false,"shares":24784,"price":71.3533,"value":1768420.1872,"ownership":{"direct":false,"nature":"By Jason Ryan Trust u/a dtd 11/25/2018"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.04 to $72.0302 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":16264,"source":{"system":"sec-edgar","filing":"0001415889-24-027473","document":"form4-11222024_011124.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000141588924027473/form4-11222024_011124.xml","form_type":"4"}},{"id":1355854,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2024-11-22T01:21:28.000Z","date":"2024-11-19","kind":"sale","planned":false,"acquired":false,"shares":5952,"price":70.8642,"value":421783.7184,"ownership":{"direct":false,"nature":"By Jason Ryan Trust u/a dtd 11/25/2018"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.026 to $71.02 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":41048,"source":{"system":"sec-edgar","filing":"0001415889-24-027473","document":"form4-11222024_011124.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000141588924027473/form4-11222024_011124.xml","form_type":"4"}},{"id":1355853,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2024-11-22T01:21:28.000Z","date":"2024-11-19","kind":"gift","planned":false,"acquired":false,"shares":141356,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Jason Ryan Trust u/a dtd 11/25/2018"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"On November 19, 2024, the reporting person transferred 141,356 shares of GeneDx Holdings Corp. Class A common stock from the reporting person's indirect holdings to the Jason Ryan 2024 GRAT (the \"GRAT\") for no consideration. The reporting person is the trustee of the GRAT, and the reporting person is the sole annuitant of the grantor retained annuity trust. The reporting person remains the beneficial owner of the securities held by the grantor retained annuity trust."}],"balance_after":47000,"source":{"system":"sec-edgar","filing":"0001415889-24-027473","document":"form4-11222024_011124.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000141588924027473/form4-11222024_011124.xml","form_type":"4"}},{"id":1384891,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2024-10-17T21:47:10.000Z","date":"2024-10-15","kind":"exercise","planned":false,"acquired":false,"shares":130,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs will vest in equal annual installments over the three-year period following the grant date of October 15, 2021, subject to the Reporting Person continuing to provide services to the Issuer through each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs will vest in equal annual installments over the three-year period following the grant date of October 15, 2021, subject to the Reporting Person continuing to provide services to the Issuer through each vesting date."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":130},"source":{"system":"sec-edgar","filing":"0001415889-24-025386","document":"form4-10172024_091007.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000141588924025386/form4-10172024_091007.xml","form_type":"4"}},{"id":1384890,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2024-10-17T21:47:10.000Z","date":"2024-10-15","kind":"exercise","planned":false,"acquired":true,"shares":130,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."}],"balance_after":73744,"source":{"system":"sec-edgar","filing":"0001415889-24-025386","document":"form4-10172024_091007.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000141588924025386/form4-10172024_091007.xml","form_type":"4"}},{"id":1468189,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2024-06-27T20:15:36.000Z","date":"2024-06-26","kind":"grant","planned":false,"acquired":true,"shares":12924,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs shall vest the earlier of (a) the date of the next annual meeting of the Issuer's shareholders following the grant date, and (b) the first anniversary of the grant date, subject to the Reporting Person continuing to provide services to the Issuer through each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs shall vest the earlier of (a) the date of the next annual meeting of the Issuer's shareholders following the grant date, and (b) the first anniversary of the grant date, subject to the Reporting Person continuing to provide services to the Issuer through each vesting date."}],"balance_after":12924,"derivative":{"underlying":"Class A Common Stock","underlying_shares":12924},"source":{"system":"sec-edgar","filing":"0001415889-24-018329","document":"form4-06272024_080631.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000141588924018329/form4-06272024_080631.xml","form_type":"4"}},{"id":1496793,"issuer":{"id":82741,"kind":"organization","name":"Singular Genomics Systems, Inc.","symbol":"OMIC"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-31T18:30:28.000Z","date":"2024-05-29","kind":"grant","planned":false,"acquired":true,"shares":74000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares vest and become exercisable upon the earlier of the 2025 Annual Meeting of Stockholders or May 29, 2025."}],"balance_after":74000,"derivative":{"exercise_price":0.372,"expiration_date":"2034-05-29","underlying":"Common Stock","underlying_shares":74000},"source":{"system":"sec-edgar","filing":"0000950170-24-067530","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850906/000095017024067530/ownership.xml","form_type":"4"}},{"id":1680118,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2024-01-12T21:31:01.000Z","date":"2024-01-11","kind":"gift","planned":false,"acquired":false,"shares":73614,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On January 11, 2024, the reporting person transferred 73,614 shares of GeneDx Holdings Corp. Class A common stock to the Jason Ryan Trust u/a dtd 11/25/2018 for no consideration. The reporting person is the trustee of the trust, and the reporting person and his spouse are the sole beneficiaries of the trust."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-24-001523","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000120919124001523/doc4.xml","form_type":"4"}},{"id":1682301,"issuer":{"id":95310,"kind":"organization","name":"SomaLogic, Inc.","symbol":"SLGC"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit (RSU)","published_at":"2024-01-10T02:53:22.000Z","date":"2024-01-05","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3400,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Company Common Stock upon settlement for no consideration."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Pursuant to the Merger Agreement, each RSU convertible into shares of Company Common Stock (a \"Company RSU\") that was outstanding immediately prior to the Effective Time, was converted into an RSU to acquire the number of shares of Parent Common Stock equal to the to the product of (i) the number of shares subject to such Company RSU as of immediately prior to the Effective Time, multiplied by (ii) the Exchange Ratio, with the resulting number of shares of Parent Common Stock rounded to the next nearest whole share. Except as noted above, each assumed Company RSU will continue to be governed by the same terms and conditions, including vesting terms and provision, as were applicable to such Company RSU immediately prior to the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The RSUs shall be 100% vested on June 8, 2024, subject to the continued service of the Reporting Person on such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The RSUs shall be 100% vested on June 8, 2024, subject to the continued service of the Reporting Person on such vesting date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3400},"source":{"system":"sec-edgar","filing":"0001209191-24-001332","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1585017/000120919124001332/doc4.xml","form_type":"4"}},{"id":1682300,"issuer":{"id":95310,"kind":"organization","name":"SomaLogic, Inc.","symbol":"SLGC"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-01-10T02:53:22.000Z","date":"2024-01-05","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":14650,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On October 4, 2023, SomaLogic, Inc., a Delaware corporation (the \"Company\") entered into the Agreement and Plan of Merger (the \"Merger Agreement\"), with Standard BioTools Inc., a Delaware corporation (\"Parent\"), and Martis Merger Sub, Inc., a Delaware corporation and a wholly owned Subsidiary of Parent (the \"Merger Sub\"). Pursuant to the Merger Agreement, on January 5, 2024, Merger Sub merged with and into the Company, with the Company surviving as a wholly-owned subsidiary of Parent (the \"Merger\"); and"},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"(Continued from Footnote 2) each option to purchase Company Common Stock (a \"Company Option\"), whether vested or unvested, that was outstanding immediately prior to the effective time of the Merger (the \"Effective Time\"), was converted into an option to acquire the number of shares of Parent Common Stock equal to the product of (i) the number of shares subject to such Company Option as of immediately prior to the Effective Time, multiplied by (ii) 1.11 shares (the \"Exchange Ratio\") of the Parent's common stock, par value $0.001 (the \"Parent Common Stock\"),"},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"(Continued from Footnote 3) rounded down to the nearest whole number of shares of the Parent Common Stock, at an exercise price per share equal to the quotient obtained by dividing the per share exercise price of the Company Option by the Exchange Ratio, rounded up to the nearest whole cent. Each such Company Option shall continue to have, and be subject to, the same terms and conditions applicable to such Company Option immediately prior to the Effective Time, including vesting terms and provisions."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option shall be 100% vested on June 8, 2024, subject to the continued service of the Reporting Person on such vesting date."}],"balance_after":0,"derivative":{"exercise_price":2.74,"expiration_date":"2033-06-07","underlying":"Common Stock","underlying_shares":14650},"source":{"system":"sec-edgar","filing":"0001209191-24-001332","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1585017/000120919124001332/doc4.xml","form_type":"4"}},{"id":1682299,"issuer":{"id":95310,"kind":"organization","name":"SomaLogic, Inc.","symbol":"SLGC"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-01-10T02:53:22.000Z","date":"2024-01-05","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":185400,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On October 4, 2023, SomaLogic, Inc., a Delaware corporation (the \"Company\") entered into the Agreement and Plan of Merger (the \"Merger Agreement\"), with Standard BioTools Inc., a Delaware corporation (\"Parent\"), and Martis Merger Sub, Inc., a Delaware corporation and a wholly owned Subsidiary of Parent (the \"Merger Sub\"). Pursuant to the Merger Agreement, on January 5, 2024, Merger Sub merged with and into the Company, with the Company surviving as a wholly-owned subsidiary of Parent (the \"Merger\"); and"},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"(Continued from Footnote 2) each option to purchase Company Common Stock (a \"Company Option\"), whether vested or unvested, that was outstanding immediately prior to the effective time of the Merger (the \"Effective Time\"), was converted into an option to acquire the number of shares of Parent Common Stock equal to the product of (i) the number of shares subject to such Company Option as of immediately prior to the Effective Time, multiplied by (ii) 1.11 shares (the \"Exchange Ratio\") of the Parent's common stock, par value $0.001 (the \"Parent Common Stock\"),"},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"(Continued from Footnote 3) rounded down to the nearest whole number of shares of the Parent Common Stock, at an exercise price per share equal to the quotient obtained by dividing the per share exercise price of the Company Option by the Exchange Ratio, rounded up to the nearest whole cent. Each such Company Option shall continue to have, and be subject to, the same terms and conditions applicable to such Company Option immediately prior to the Effective Time, including vesting terms and provisions."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 1/4th of the total grant on June 8, 2024, and thereafter 1/36th of the total grant vests monthly until such time as the option is 100% vested, subject to the continued service of the Reporting Person on each vesting date."}],"balance_after":0,"derivative":{"exercise_price":2.74,"expiration_date":"2033-06-07","underlying":"Common Stock","underlying_shares":185400},"source":{"system":"sec-edgar","filing":"0001209191-24-001332","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1585017/000120919124001332/doc4.xml","form_type":"4"}},{"id":1693017,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Restricted Stock Unit","published_at":"2024-01-03T21:23:55.000Z","date":"2023-12-31","kind":"exercise","planned":false,"acquired":false,"shares":46000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% of the underlying awards shall become vested on the earlier of (A) December 31, 2023, and (B) a change in control of the Issuer, subject to the Reporting Person's continued service to the Issuer on such earlier date, or upon a termination of the Reporting Person's service as Executive Chairman of the Board under certain circumstances."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"100% of the underlying awards shall become vested on the earlier of (A) December 31, 2023, and (B) a change in control of the Issuer, subject to the Reporting Person's continued service to the Issuer on such earlier date, or upon a termination of the Reporting Person's service as Executive Chairman of the Board under certain circumstances."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":46000},"source":{"system":"sec-edgar","filing":"0001209191-24-000371","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000120919124000371/doc4.xml","form_type":"4"}},{"id":1693016,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Restricted Stock Unit","published_at":"2024-01-03T21:23:55.000Z","date":"2023-12-31","kind":"exercise","planned":false,"acquired":false,"shares":21780,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% of the underlying awards shall become vested on the earlier of (A) December 31, 2023, and (B) a change in control of the Issuer, subject to the Reporting Person's continued service to the Issuer on such earlier date, or upon a termination of the Reporting Person's service as Executive Chairman of the Board under certain circumstances."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"100% of the underlying awards shall become vested on the earlier of (A) December 31, 2023, and (B) a change in control of the Issuer, subject to the Reporting Person's continued service to the Issuer on such earlier date, or upon a termination of the Reporting Person's service as Executive Chairman of the Board under certain circumstances."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":21780},"source":{"system":"sec-edgar","filing":"0001209191-24-000371","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000120919124000371/doc4.xml","form_type":"4"}},{"id":1693015,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Class A Common Stock","published_at":"2024-01-03T21:23:55.000Z","date":"2023-12-31","kind":"exercise","planned":false,"acquired":true,"shares":67780,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."}],"balance_after":73614,"source":{"system":"sec-edgar","filing":"0001209191-24-000371","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000120919124000371/doc4.xml","form_type":"4"}},{"id":1734789,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Class A Common Stock","published_at":"2023-11-20T21:32:17.000Z","date":"2023-11-17","kind":"purchase","planned":false,"acquired":true,"shares":58000,"price":1.5376,"value":89180.8,"ownership":{"direct":false,"nature":"By Jason Ryan Trust u/a dtd 11/25/2018"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.41 to $1.61, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein."}],"balance_after":114742,"source":{"system":"sec-edgar","filing":"0001209191-23-056073","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000120919123056073/doc4.xml","form_type":"4"}},{"id":1734788,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Class A Common Stock","published_at":"2023-11-20T21:32:17.000Z","date":"2023-11-16","kind":"purchase","planned":false,"acquired":true,"shares":56742,"price":1.2722,"value":72187.1724,"ownership":{"direct":false,"nature":"By Jason Ryan Trust u/a dtd 11/25/2018"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.175 to $1.395, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein."}],"balance_after":56742,"source":{"system":"sec-edgar","filing":"0001209191-23-056073","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000120919123056073/doc4.xml","form_type":"4"}},{"id":1758192,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Class A Common Stock","published_at":"2023-10-18T20:59:21.000Z","date":"2023-10-17","kind":"sale","planned":false,"acquired":false,"shares":42,"price":3.19,"value":133.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":5834,"source":{"system":"sec-edgar","filing":"0001209191-23-053094","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000120919123053094/doc4.xml","form_type":"4"}},{"id":1759083,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Restricted Stock Unit","published_at":"2023-10-17T22:50:03.000Z","date":"2023-10-15","kind":"exercise","planned":false,"acquired":false,"shares":129,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs will vest in equal annual installments over the three-year period following the grant date of October 15, 2021, subject to the Reporting Person continuing to provide services to the Issuer through each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs will vest in equal annual installments over the three-year period following the grant date of October 15, 2021, subject to the Reporting Person continuing to provide services to the Issuer through each vesting date."}],"balance_after":130,"derivative":{"underlying":"Class A Common Stock","underlying_shares":129},"source":{"system":"sec-edgar","filing":"0001209191-23-053013","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000120919123053013/doc4.xml","form_type":"4"}},{"id":1759082,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Class A Common Stock","published_at":"2023-10-17T22:50:03.000Z","date":"2023-10-15","kind":"exercise","planned":false,"acquired":true,"shares":129,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."}],"balance_after":5876,"source":{"system":"sec-edgar","filing":"0001209191-23-053013","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000120919123053013/doc4.xml","form_type":"4"}},{"id":1858346,"issuer":{"id":95310,"kind":"organization","name":"SomaLogic, Inc.","symbol":"SLGC"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit (RSU)","published_at":"2023-06-13T01:25:04.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":3400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs shall be 100% vested on June 8, 2024, subject to the continued service of the Reporting Person on such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs shall be 100% vested on June 8, 2024, subject to the continued service of the Reporting Person on such vesting date."}],"balance_after":3400,"derivative":{"underlying":"Common Stock","underlying_shares":3400},"source":{"system":"sec-edgar","filing":"0001209191-23-036547","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1585017/000120919123036547/doc4.xml","form_type":"4"}},{"id":1858345,"issuer":{"id":95310,"kind":"organization","name":"SomaLogic, Inc.","symbol":"SLGC"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-06-13T01:25:04.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":14650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall be 100% vested on June 8, 2024, subject to the continued service of the Reporting Person on such vesting date."}],"balance_after":14650,"derivative":{"exercise_price":2.74,"expiration_date":"2033-06-07","underlying":"Common Stock","underlying_shares":14650},"source":{"system":"sec-edgar","filing":"0001209191-23-036547","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1585017/000120919123036547/doc4.xml","form_type":"4"}},{"id":1858344,"issuer":{"id":95310,"kind":"organization","name":"SomaLogic, Inc.","symbol":"SLGC"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-06-13T01:25:04.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":185400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 1/4 of the total grant on June 8, 2024, and thereafter 1/36th of the total grant vest monthly until such time as the option is 100% vested, subject to the continued service of the Reporting Person on each vesting date."}],"balance_after":185400,"derivative":{"exercise_price":2.74,"expiration_date":"2033-06-07","underlying":"Common Stock","underlying_shares":185400},"source":{"system":"sec-edgar","filing":"0001209191-23-036547","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1585017/000120919123036547/doc4.xml","form_type":"4"}},{"id":1876706,"issuer":{"id":82741,"kind":"organization","name":"Singular Genomics Systems, Inc.","symbol":"OMIC"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-26T17:03:15.000Z","date":"2023-05-25","kind":"grant","planned":false,"acquired":true,"shares":74000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares vest and become exercisable upon the earlier of the 2024 Stockholder Annual Meeting or May 25, 2024."}],"balance_after":74000,"derivative":{"exercise_price":1.06,"expiration_date":"2033-05-25","underlying":"Common Stock","underlying_shares":74000},"source":{"system":"sec-edgar","filing":"0001209191-23-032600","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850906/000120919123032600/doc4.xml","form_type":"4"}},{"id":1912423,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Restricted Stock Unit","published_at":"2023-04-27T23:39:06.000Z","date":"2023-04-26","kind":"grant","planned":false,"acquired":true,"shares":1518000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% of the underlying awards shall become vested and exercisable on the earlier of (A) December 31, 2023, and (B) a change in control of the Issuer, subject to the Reporting Person's continued service to the Issuer on such earlier date, or upon a termination of the Reporting Person's service as Executive Chairman of the Board under certain circumstances."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"100% of the underlying awards shall become vested and exercisable on the earlier of (A) December 31, 2023, and (B) a change in control of the Issuer, subject to the Reporting Person's continued service to the Issuer on such earlier date, or upon a termination of the Reporting Person's service as Executive Chairman of the Board under certain circumstances."}],"balance_after":1518000,"derivative":{"underlying":"Class A Common Stock","underlying_shares":1518000},"source":{"system":"sec-edgar","filing":"0001209191-23-025918","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000120919123025918/doc4.xml","form_type":"4"}},{"id":2068372,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Restricted Stock Unit","published_at":"2023-01-05T00:46:59.000Z","date":"2022-12-31","kind":"exercise","acquired":false,"shares":247525,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"100% of the RSUs vested as of December 31, 2022, subject to the Reporting Person's continued service to the Issuer on such earlier date, or upon a termination of the Reporting Person's service as Executive Chairman of the Board under certain circumstances."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"100% of the RSUs vested as of December 31, 2022, subject to the Reporting Person's continued service to the Issuer on such earlier date, or upon a termination of the Reporting Person's service as Executive Chairman of the Board under certain circumstances."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":247525},"source":{"system":"sec-edgar","filing":"0001209191-23-001437","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000120919123001437/doc4.xml","form_type":"4"}},{"id":2068371,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Class A Common Stock","published_at":"2023-01-05T00:46:59.000Z","date":"2022-12-31","kind":"sale","acquired":false,"shares":73732,"price":0.2619,"value":19310.4108,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":189626,"source":{"system":"sec-edgar","filing":"0001209191-23-001437","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000120919123001437/doc4.xml","form_type":"4"}},{"id":2068370,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Class A Common Stock","published_at":"2023-01-05T00:46:59.000Z","date":"2022-12-31","kind":"exercise","acquired":true,"shares":247525,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."}],"balance_after":263358,"source":{"system":"sec-edgar","filing":"0001209191-23-001437","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000120919123001437/doc4.xml","form_type":"4"}},{"id":2086610,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Restricted Stock Unit","published_at":"2022-12-14T21:11:09.000Z","date":"2022-12-09","kind":"grant","acquired":true,"shares":718753,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"6.25% vest in quarterly installments over the 4-year period commencing on December 9, 2022 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date."}],"balance_after":718753,"derivative":{"expiration_date":"2026-12-09","underlying":"Class A  Common Stock","underlying_shares":718753},"source":{"system":"sec-edgar","filing":"0001209191-22-061182","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000120919122061182/doc4.xml","form_type":"4"}},{"id":2135641,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Restricted Stock Unit","published_at":"2022-10-18T22:36:24.000Z","date":"2022-10-15","kind":"exercise","acquired":false,"shares":4278,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs will vest in equal annual installments over the three-year period following the grant date of October 15, 2021, subject to the Reporting Person continuing to provide services to the Issuer through each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs will vest in equal annual installments over the three-year period following the grant date of October 15, 2021, subject to the Reporting Person continuing to provide services to the Issuer through each vesting date."}],"balance_after":8558,"derivative":{"underlying":"Class A Common Stock","underlying_shares":4278},"source":{"system":"sec-edgar","filing":"0001209191-22-054000","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000120919122054000/doc4.xml","form_type":"4"}},{"id":2135640,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Class A Common Stock","published_at":"2022-10-18T22:36:24.000Z","date":"2022-10-17","kind":"sale","acquired":false,"shares":1281,"price":0.8598,"value":1101.4038,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":15833,"source":{"system":"sec-edgar","filing":"0001209191-22-054000","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000120919122054000/doc4.xml","form_type":"4"}},{"id":2135639,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Class A Common Stock","published_at":"2022-10-18T22:36:24.000Z","date":"2022-10-15","kind":"exercise","acquired":true,"shares":4278,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."}],"balance_after":17114,"source":{"system":"sec-edgar","filing":"0001209191-22-054000","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000120919122054000/doc4.xml","form_type":"4"}},{"id":2251608,"issuer":{"id":82741,"kind":"organization","name":"Singular Genomics Systems, Inc.","symbol":"OMIC"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-31T21:05:05.000Z","date":"2022-05-26","kind":"grant","acquired":true,"shares":46250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares vest and become exercisable upon the earlier of the 2023 Stockholder Annual Meeting or May 26, 2023."}],"balance_after":46250,"derivative":{"exercise_price":2.86,"expiration_date":"2032-05-26","underlying":"Common Stock","underlying_shares":46250},"source":{"system":"sec-edgar","filing":"0001209191-22-033020","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850906/000120919122033020/doc4.xml","form_type":"4"}},{"id":2273614,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2022-05-13T00:23:13.000Z","date":"2022-04-27","kind":"exercise","acquired":false,"shares":12836,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs will vest on the earlier of (i) the date of the next annual meeting of the Company's shareholders following the grant date and (i) the first anniversary of the grant date, in each case so long as the non-employee director continues to provide services to the Company through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs will vest on the earlier of (i) the date of the next annual meeting of the Company's shareholders following the grant date and (i) the first anniversary of the grant date, in each case so long as the non-employee director continues to provide services to the Company through such vesting date."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":12836},"source":{"system":"sec-edgar","filing":"0001209191-22-028691","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000120919122028691/doc4.xml","form_type":"4"}},{"id":2273613,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2022-05-13T00:23:13.000Z","date":"2022-04-27","kind":"exercise","acquired":true,"shares":12836,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."}],"balance_after":12836,"source":{"system":"sec-edgar","filing":"0001209191-22-028691","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000120919122028691/doc4.xml","form_type":"4"}},{"id":2430751,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2022-01-20T23:45:47.000Z","date":"2022-01-18","kind":"grant","acquired":true,"shares":247525,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A common stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the underlying awards shall become vested and exercisable on the earlier of (A) December 31, 2022, and (B) a change in control of the Issuer, subject to the Reporting Person's continued service to the Issuer on such earlier date, or upon a termination of the Reporting Person's service as Executive Chairman of the Board under certain circumstances."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"100% of the underlying awards shall become vested and exercisable on the earlier of (A) December 31, 2022, and (B) a change in control of the Issuer, subject to the Reporting Person's continued service to the Issuer on such earlier date, or upon a termination of the Reporting Person's service as Executive Chairman of the Board under certain circumstances."}],"balance_after":247525,"derivative":{"underlying":"Class A Common Stock","underlying_shares":247525},"source":{"system":"sec-edgar","filing":"0001209191-22-004176","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000120919122004176/doc4.xml","form_type":"4"}},{"id":2430750,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-01-20T23:45:47.000Z","date":"2022-01-18","kind":"grant","acquired":true,"shares":429730,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the underlying awards shall become vested and exercisable on the earlier of (A) December 31, 2022, and (B) a change in control of the Issuer, subject to the Reporting Person's continued service to the Issuer on such earlier date, or upon a termination of the Reporting Person's service as Executive Chairman of the Board under certain circumstances."}],"balance_after":429730,"derivative":{"exercise_price":3.45,"expiration_date":"2032-01-17","underlying":"Class A Common Stock","underlying_shares":429730},"source":{"system":"sec-edgar","filing":"0001209191-22-004176","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000120919122004176/doc4.xml","form_type":"4"}},{"id":2539473,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2021-10-19T23:24:24.000Z","date":"2021-10-15","kind":"grant","acquired":true,"shares":12836,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs will vest in equal annual installments over the three-year period following the grant date, subject to the Reporting Person continuing to provide services to the Issuer through each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs will vest in equal annual installments over the three-year period following the grant date, subject to the Reporting Person continuing to provide services to the Issuer through each vesting date."}],"balance_after":12836,"derivative":{"underlying":"Class A Common Stock","underlying_shares":12836},"source":{"system":"sec-edgar","filing":"0001209191-21-061026","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000120919121061026/doc4.xml","form_type":"4"}},{"id":2539472,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2021-10-19T23:24:24.000Z","date":"2021-10-15","kind":"grant","acquired":true,"shares":12836,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options and restricted stock units (\"RSUs\") will vest on the earlier of (i) the date of the next annual meeting of the Issuer's shareholders following the grant date and (i) the first anniversary of the grant date, in each case so long as the Reporting Person continues to provide services to the Issuer through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The stock options and restricted stock units (\"RSUs\") will vest on the earlier of (i) the date of the next annual meeting of the Issuer's shareholders following the grant date and (i) the first anniversary of the grant date, in each case so long as the Reporting Person continues to provide services to the Issuer through such vesting date."}],"balance_after":12836,"derivative":{"underlying":"Class A Common Stock","underlying_shares":12836},"source":{"system":"sec-edgar","filing":"0001209191-21-061026","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000120919121061026/doc4.xml","form_type":"4"}},{"id":2539471,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-10-19T23:24:24.000Z","date":"2021-10-15","kind":"grant","acquired":true,"shares":22286,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option shall vest as of 1/36 of the total shares monthly beginning on November 15, 2021 until fully vested, subject to the Reporting Person continuing to provide services to the Issuer through each vesting date."}],"balance_after":22286,"derivative":{"exercise_price":7.79,"expiration_date":"2031-10-14","underlying":"Class A Common Stock","underlying_shares":22286},"source":{"system":"sec-edgar","filing":"0001209191-21-061026","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000120919121061026/doc4.xml","form_type":"4"}},{"id":2539470,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-10-19T23:24:24.000Z","date":"2021-10-15","kind":"grant","acquired":true,"shares":22286,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options and restricted stock units (\"RSUs\") will vest on the earlier of (i) the date of the next annual meeting of the Issuer's shareholders following the grant date and (i) the first anniversary of the grant date, in each case so long as the Reporting Person continues to provide services to the Issuer through such vesting date."}],"balance_after":22286,"derivative":{"exercise_price":7.79,"expiration_date":"2031-10-14","underlying":"Class A Common Stock","underlying_shares":22286},"source":{"system":"sec-edgar","filing":"0001209191-21-061026","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000120919121061026/doc4.xml","form_type":"4"}},{"id":3277177,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-12T22:15:05.000Z","date":"2020-02-10","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in 16 equal quarterly installments beginning on January 1, 2020."}],"balance_after":75000,"derivative":{"exercise_price":12.28,"expiration_date":"2030-02-09","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0000899243-20-004316","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000089924320004316/doc4.xml","form_type":"4"}},{"id":3704244,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-04T21:16:43.000Z","date":"2019-01-02","kind":"grant","acquired":true,"shares":329379,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exerciseable over four years, with 25% of this option vesting on January 1, 2020, and the remainder vesting in 36 equal monthly installments thereafter."}],"balance_after":329379,"derivative":{"exercise_price":6,"expiration_date":"2029-01-01","underlying":"Common Stock","underlying_shares":329379},"source":{"system":"sec-edgar","filing":"0000899243-19-000527","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000089924319000527/doc4.xml","form_type":"4"}},{"id":3855004,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"stock option (right to buy)","published_at":"2018-08-02T16:09:44.000Z","date":"2018-07-31","kind":"other","acquired":false,"shares":1562,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Foundation Medicine, Inc., a Delaware corporation (the \"Company\") entered into an Agreement and Plan of Merger, dated as of June 18, 2018, as amended (the \"Merger Agreement\"), with Roche Holdings, Inc., a Delaware corporation (\"Parent\" or \"Roche\"), and 062018 Merger Subsidiary, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (\"Merger Sub\"). Pursuant to the Merger Agreement, Parent caused Merger Sub to conduct a tender offer (the \"Tender Offer\") for all of the issued and outstanding shares of common stock, par value $0.0001 per share, of the Company, at a price of $137 per share. On July 31, 2018, Merger Sub irrevocably accepted for payment all shares that were validly tendered and not withdrawn. On July 31, 2018, following consummation of the Tender Offer, Merger Sub merged with and into the Company."},{"field":"shares","element":"transactionShares","label":"F4","text":"The amount reported represents the number of vested stock options cancelled in connection with the Tender Offer by Roche and converted into the right to receive an amount in cash equal to the product of (1) the offer price of $137 per share minus the per share exercise price of the vested stock options, multiplied by (2) the number of shares represented by such vested stock options, without interest and less any required withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option was granted on May 21, 2013 and vested in equal quarterly installments beginning on April 1, 2014 until fully vested on January 1, 2018."}],"balance_after":0,"derivative":{"exercise_price":7.12,"expiration_date":"2023-05-21","underlying":"Common Stock","underlying_shares":1562},"source":{"system":"sec-edgar","filing":"0001209191-18-044936","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118044936/doc4.xml","form_type":"4"}},{"id":3855003,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-08-02T16:09:44.000Z","date":"2018-07-31","kind":"other","acquired":false,"shares":42215,"price":137,"value":5783455.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Foundation Medicine, Inc., a Delaware corporation (the \"Company\") entered into an Agreement and Plan of Merger, dated as of June 18, 2018, as amended (the \"Merger Agreement\"), with Roche Holdings, Inc., a Delaware corporation (\"Parent\" or \"Roche\"), and 062018 Merger Subsidiary, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (\"Merger Sub\"). Pursuant to the Merger Agreement, Parent caused Merger Sub to conduct a tender offer (the \"Tender Offer\") for all of the issued and outstanding shares of common stock, par value $0.0001 per share, of the Company, at a price of $137 per share. On July 31, 2018, Merger Sub irrevocably accepted for payment all shares that were validly tendered and not withdrawn. On July 31, 2018, following consummation of the Tender Offer, Merger Sub merged with and into the Company."},{"field":"shares","element":"transactionShares","label":"F3","text":"The amount reported represents the number of unvested restricted stock units cancelled in connection with the Tender Offer by Roche and converted into the right to receive an amount in cash equal to the product of (1) the offer price of $137 per share multiplied by (2) the number of shares represented by such unvested restricted stock units, without interest and less any required withholding taxes. Payments are subject to the original vesting schedule and vesting conditions applicable to the underlying unvested restricted stock units."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-18-044936","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118044936/doc4.xml","form_type":"4"}},{"id":3855002,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-08-02T16:09:44.000Z","date":"2018-07-31","kind":"other","acquired":false,"shares":6955,"price":137,"value":952835.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Foundation Medicine, Inc., a Delaware corporation (the \"Company\") entered into an Agreement and Plan of Merger, dated as of June 18, 2018, as amended (the \"Merger Agreement\"), with Roche Holdings, Inc., a Delaware corporation (\"Parent\" or \"Roche\"), and 062018 Merger Subsidiary, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (\"Merger Sub\"). Pursuant to the Merger Agreement, Parent caused Merger Sub to conduct a tender offer (the \"Tender Offer\") for all of the issued and outstanding shares of common stock, par value $0.0001 per share, of the Company, at a price of $137 per share. On July 31, 2018, Merger Sub irrevocably accepted for payment all shares that were validly tendered and not withdrawn. On July 31, 2018, following consummation of the Tender Offer, Merger Sub merged with and into the Company."},{"field":"shares","element":"transactionShares","label":"F2","text":"The amount reported represents the number of shares sold by the reporting person in connection with the Tender Offer by Roche."}],"balance_after":42215,"source":{"system":"sec-edgar","filing":"0001209191-18-044936","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118044936/doc4.xml","form_type":"4"}},{"id":3872644,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-07-05T16:10:27.000Z","date":"2018-07-02","kind":"sale","acquired":false,"shares":3403,"price":136.66,"value":465053.98,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units on July 1, 2018. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a \"sell to cover\" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The reporting person previously reported restricted stock units granted to the reporting person on (1) April 1, 2016 in Table I of the Form 4 filed on April 6, 2016, (2) May 1, 2017 in Table I of the Form 4 filed on May 3, 2017 and (3) April 1, 2018 in Table I of the Form 4 filed on April 3, 2018. As such, no adjustment to the reporting person's beneficial interest needs to be made to reflect the vesting events related to this securities sale."}],"balance_after":49170,"source":{"system":"sec-edgar","filing":"0001209191-18-041561","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118041561/doc4.xml","form_type":"4"}},{"id":3961040,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-04-18T16:08:48.000Z","date":"2018-04-16","kind":"sale","acquired":false,"shares":3449,"price":74.3,"value":256260.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale of these shares were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 7, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $72.00 to $79.55, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote."}],"balance_after":52573,"source":{"system":"sec-edgar","filing":"0001209191-18-025357","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118025357/doc4.xml","form_type":"4"}},{"id":3968416,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-04-05T16:15:49.000Z","date":"2018-04-03","kind":"sale","acquired":false,"shares":1,"price":72.4,"value":72.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units on April 1, 2018. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a \"sell to cover\" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The reporting person previously reported restricted stock units granted to the reporting person on April 1, 2016 in Table I of the Form 4 filed on April 6, 2016. As such, no adjustment to the reporting person's beneficial interest needs to be made to reflect the vesting event related to this securities sale."}],"balance_after":56022,"source":{"system":"sec-edgar","filing":"0001209191-18-024051","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118024051/doc4.xml","form_type":"4"}},{"id":3973043,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-04-03T16:13:40.000Z","date":"2018-04-02","kind":"sale","acquired":false,"shares":3030,"price":74.87,"value":226856.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units on April 1, 2018. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a \"sell to cover\" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $71.60 to $75.00, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"The reporting person previously reported restricted stock units granted to the reporting person on April 1, 2016 in Table I of the Form 4 filed on April 6, 2016. As such, no adjustment to the reporting person's beneficial interest needs to be made to reflect the vesting event related to this securities sale."}],"balance_after":56023,"source":{"system":"sec-edgar","filing":"0001209191-18-022900","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118022900/doc4.xml","form_type":"4"}},{"id":3973042,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-04-03T16:13:40.000Z","date":"2018-04-02","kind":"sale","acquired":false,"shares":3109,"price":77.55,"value":241102.95,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The sale of these shares were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 7, 2017."}],"balance_after":59053,"source":{"system":"sec-edgar","filing":"0001209191-18-022900","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118022900/doc4.xml","form_type":"4"}},{"id":3973041,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-04-03T16:13:40.000Z","date":"2018-04-01","kind":"grant","acquired":true,"shares":12932,"price":78.75,"value":1018395.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units issued pursuant to a Restricted Stock Unit Award Agreement and the Issuer's 2013 Stock Option and Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest in equal quarterly installments over a three-year period with the first installment vesting on July 1, 2018."}],"balance_after":62162,"source":{"system":"sec-edgar","filing":"0001209191-18-022900","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118022900/doc4.xml","form_type":"4"}},{"id":3989566,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock (right to buy)","published_at":"2018-03-19T16:17:54.000Z","date":"2018-03-15","kind":"exercise","acquired":false,"shares":7853,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on February 6, 2014 and vested in equal quarterly installments beginning on April 1, 2014 until fully vested on January 1, 2018."}],"balance_after":0,"derivative":{"exercise_price":29.63,"expiration_date":"2024-02-06","underlying":"Common Stock","underlying_shares":7853},"source":{"system":"sec-edgar","filing":"0001209191-18-020566","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118020566/doc4.xml","form_type":"4"}},{"id":3989565,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock (right to buy)","published_at":"2018-03-19T16:17:54.000Z","date":"2018-03-15","kind":"exercise","acquired":false,"shares":7147,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on February 6, 2014 and vested in equal quarterly installments beginning on April 1, 2014 until fully vested on January 1, 2018."}],"balance_after":0,"derivative":{"exercise_price":29.63,"expiration_date":"2024-02-06","underlying":"Common Stock","underlying_shares":7147},"source":{"system":"sec-edgar","filing":"0001209191-18-020566","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118020566/doc4.xml","form_type":"4"}},{"id":3989564,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-03-19T16:17:54.000Z","date":"2018-03-15","kind":"sale","acquired":false,"shares":7853,"price":78.26,"value":614575.78,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 7, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $77.50 to $79.45, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote."}],"balance_after":49230,"source":{"system":"sec-edgar","filing":"0001209191-18-020566","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118020566/doc4.xml","form_type":"4"}},{"id":3989563,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-03-19T16:17:54.000Z","date":"2018-03-15","kind":"exercise","acquired":true,"shares":7853,"price":29.63,"value":232684.39,"ownership":{"direct":true},"balance_after":57083,"source":{"system":"sec-edgar","filing":"0001209191-18-020566","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118020566/doc4.xml","form_type":"4"}},{"id":3989562,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-03-19T16:17:54.000Z","date":"2018-03-15","kind":"sale","acquired":false,"shares":7147,"price":78.26,"value":559324.22,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 7, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $77.50 to $79.45, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote."}],"balance_after":49230,"source":{"system":"sec-edgar","filing":"0001209191-18-020566","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118020566/doc4.xml","form_type":"4"}},{"id":3989561,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-03-19T16:17:54.000Z","date":"2018-03-15","kind":"exercise","acquired":true,"shares":7147,"price":29.63,"value":211765.61,"ownership":{"direct":true},"balance_after":56377,"source":{"system":"sec-edgar","filing":"0001209191-18-020566","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118020566/doc4.xml","form_type":"4"}},{"id":4047608,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock (right to buy)","published_at":"2018-02-20T16:05:38.000Z","date":"2018-02-15","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on February 6, 2014 and vested in equal quarterly installments beginning on April 1, 2014 until fully vested on January 1, 2018."}],"balance_after":7147,"derivative":{"exercise_price":29.63,"expiration_date":"2024-02-06","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-18-011252","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118011252/doc4.xml","form_type":"4"}},{"id":4047607,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-02-20T16:05:38.000Z","date":"2018-02-15","kind":"sale","acquired":false,"shares":15000,"price":67.53,"value":1012950.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 7, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $66.55 to $68.85, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote."}],"balance_after":49230,"source":{"system":"sec-edgar","filing":"0001209191-18-011252","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118011252/doc4.xml","form_type":"4"}},{"id":4047606,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-02-20T16:05:38.000Z","date":"2018-02-15","kind":"exercise","acquired":true,"shares":15000,"price":29.63,"value":444450.0,"ownership":{"direct":true},"balance_after":64230,"source":{"system":"sec-edgar","filing":"0001209191-18-011252","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118011252/doc4.xml","form_type":"4"}},{"id":4096173,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock (right to buy)","published_at":"2018-01-18T16:05:34.000Z","date":"2018-01-16","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on February 6, 2014 and vested in equal quarterly installments beginning on April 1, 2014 until fully vested on January 1, 2018."}],"balance_after":22147,"derivative":{"exercise_price":29.63,"expiration_date":"2024-02-06","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-18-004231","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118004231/doc4.xml","form_type":"4"}},{"id":4096172,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-01-18T16:05:34.000Z","date":"2018-01-16","kind":"sale","acquired":false,"shares":20000,"price":64.38,"value":1287600.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 7, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $62.65 to $68.65, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote."}],"balance_after":49230,"source":{"system":"sec-edgar","filing":"0001209191-18-004231","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118004231/doc4.xml","form_type":"4"}},{"id":4096171,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-01-18T16:05:34.000Z","date":"2018-01-16","kind":"exercise","acquired":true,"shares":20000,"price":29.63,"value":592600.0,"ownership":{"direct":true},"balance_after":69230,"source":{"system":"sec-edgar","filing":"0001209191-18-004231","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118004231/doc4.xml","form_type":"4"}},{"id":4096170,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-01-18T16:05:34.000Z","date":"2018-01-16","kind":"sale","acquired":false,"shares":1035,"price":64.38,"value":66633.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 7, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $62.65 to $68.65, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote."}],"balance_after":49230,"source":{"system":"sec-edgar","filing":"0001209191-18-004231","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118004231/doc4.xml","form_type":"4"}},{"id":4112033,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-01-03T17:19:56.000Z","date":"2018-01-02","kind":"sale","acquired":false,"shares":944,"price":64,"value":60416.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units on January 1, 2018. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a \"sell to cover\" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $61.73 to $64.12, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"The reporting person previously reported the restricted stock units granted to the reporting person on May 1, 2017 in Table I of the Form 4 filed on May 3, 2017.  As such, no adjustment to the reporting persons beneficial interest needs to be made to reflect the vesting event related to this securities sale."}],"balance_after":50265,"source":{"system":"sec-edgar","filing":"0001209191-18-001139","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118001139/doc4.xml","form_type":"4"}},{"id":4112032,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-01-03T17:19:56.000Z","date":"2018-01-02","kind":"sale","acquired":false,"shares":1392,"price":64,"value":89088.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units on January 1, 2018. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a \"sell to cover\" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $61.73 to $64.12, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The reporting person previously reported restricted stock units granted to the reporting person on April 1, 2016 in Table I of the Form 4 filed on April 6, 2016. As such, no adjustment to the reporting person's beneficial interest needs to be made to reflect the vesting event related to this securities sale."}],"balance_after":51209,"source":{"system":"sec-edgar","filing":"0001209191-18-001139","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118001139/doc4.xml","form_type":"4"}},{"id":4139220,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"stock option (right to buy)","published_at":"2017-12-07T16:05:36.000Z","date":"2017-12-05","kind":"exercise","acquired":false,"shares":18688,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on May 21, 2013 and vests in equal quarterly installments beginning on April 1, 2014 until fully vested on January 1, 2018."}],"balance_after":1562,"derivative":{"exercise_price":7.12,"expiration_date":"2023-05-21","underlying":"Common Stock","underlying_shares":18688},"source":{"system":"sec-edgar","filing":"0001209191-17-064399","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919117064399/doc4.xml","form_type":"4"}},{"id":4139219,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"stock option (right to buy)","published_at":"2017-12-07T16:05:36.000Z","date":"2017-12-05","kind":"exercise","acquired":false,"shares":3038,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on June 15, 2011. Twenty-five percent vested on May 16, 2012 and an additional 6.25% vested in equal quarterly installments until fully vested on May 16, 2015."}],"balance_after":0,"derivative":{"exercise_price":0.08,"expiration_date":"2021-06-15","underlying":"Common Stock","underlying_shares":3038},"source":{"system":"sec-edgar","filing":"0001209191-17-064399","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919117064399/doc4.xml","form_type":"4"}},{"id":4139218,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-12-07T16:05:36.000Z","date":"2017-12-05","kind":"sale","acquired":false,"shares":18688,"price":61.26,"value":1144826.88,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $60.35 to $62.85, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote."}],"balance_after":52601,"source":{"system":"sec-edgar","filing":"0001209191-17-064399","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919117064399/doc4.xml","form_type":"4"}},{"id":4139217,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-12-07T16:05:36.000Z","date":"2017-12-05","kind":"exercise","acquired":true,"shares":18688,"price":7.12,"value":133058.56,"ownership":{"direct":true},"balance_after":71289,"source":{"system":"sec-edgar","filing":"0001209191-17-064399","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919117064399/doc4.xml","form_type":"4"}},{"id":4139216,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-12-07T16:05:36.000Z","date":"2017-12-05","kind":"sale","acquired":false,"shares":3038,"price":61.26,"value":186107.88,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $60.35 to $62.85, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote."}],"balance_after":52601,"source":{"system":"sec-edgar","filing":"0001209191-17-064399","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919117064399/doc4.xml","form_type":"4"}},{"id":4139215,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-12-07T16:05:36.000Z","date":"2017-12-05","kind":"exercise","acquired":true,"shares":3038,"price":0.08,"value":243.04,"ownership":{"direct":true},"balance_after":55639,"source":{"system":"sec-edgar","filing":"0001209191-17-064399","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919117064399/doc4.xml","form_type":"4"}},{"id":4171361,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-11-06T16:02:18.000Z","date":"2017-11-02","kind":"sale","acquired":false,"shares":9731,"price":50,"value":486550.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 26, 2016."}],"balance_after":52601,"source":{"system":"sec-edgar","filing":"0001209191-17-059395","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919117059395/doc4.xml","form_type":"4"}},{"id":4185738,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-10-16T16:10:22.000Z","date":"2017-10-12","kind":"sale","acquired":false,"shares":1152,"price":45.05,"value":51897.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 26, 2016. The sale of a portion of these shares were effected to cover tax liabilities of the reporting person in connection with the vesting and release of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The reporting person previously reported restricted stock units granted to the reporting person on April 1, 2016 in Table I of the Form 4 filed on April 6, 2016. As such, no adjustment to the reporting person's beneficial interest needs to be made to reflect the vesting event related to this securities sale."}],"balance_after":62332,"source":{"system":"sec-edgar","filing":"0001209191-17-057008","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919117057008/doc4.xml","form_type":"4"}},{"id":4192156,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-10-04T16:05:23.000Z","date":"2017-10-02","kind":"sale","acquired":false,"shares":1325,"price":38.8,"value":51410.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units on October 1, 2017. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a \"sell to cover\" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.46 to $38.80, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"The reporting person previously reported the restricted stock units granted to the reporting person on May 1, 2017 in Table I of the Form 4 filed on May 3, 2017.  As such, no adjustment to the reporting persons beneficial interest needs to be made to reflect the vesting event related to this securities sale."}],"balance_after":63484,"source":{"system":"sec-edgar","filing":"0001209191-17-055747","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919117055747/doc4.xml","form_type":"4"}},{"id":4192155,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-10-04T16:05:23.000Z","date":"2017-10-02","kind":"sale","acquired":false,"shares":1829,"price":38.8,"value":70965.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units on October 1, 2017. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a \"sell to cover\" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.46 to $38.80, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The reporting person previously reported restricted stock units granted to the reporting person on April 1, 2016 in Table I of the Form 4 filed on April 6, 2016. As such, no adjustment to the reporting person's beneficial interest needs to be made to reflect the vesting event related to this securities sale."}],"balance_after":64809,"source":{"system":"sec-edgar","filing":"0001209191-17-055747","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919117055747/doc4.xml","form_type":"4"}},{"id":4256416,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-07-17T16:02:17.000Z","date":"2017-07-13","kind":"sale","acquired":false,"shares":5084,"price":39.77,"value":202190.68,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 26, 2016. The sale of a portion of these shares were effected to cover tax liabilities of the reporting person in connection with the vesting and release of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $39.30 to $40.00, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote."}],"balance_after":66638,"source":{"system":"sec-edgar","filing":"0001209191-17-045331","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919117045331/doc4.xml","form_type":"4"}},{"id":4260879,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-07-07T16:04:31.000Z","date":"2017-07-06","kind":"sale","acquired":false,"shares":1308,"price":38.84,"value":50802.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units on July 1, 2017. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a \"sell to cover\" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in this Column 4 is a weighted average price. The shares were sold as part of a group sale of shares in multiple transactions at prices ranging from $36.85 to $40.05, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"The reporting person previously reported the restricted stock units granted to the reporting person on May 1, 2017 in Table I of the Form 4 filed on May 3, 2017.  As such, no adjustment to the reporting persons beneficial interest needs to be made to reflect the vesting event related to this securities sale."}],"balance_after":71722,"source":{"system":"sec-edgar","filing":"0001209191-17-044363","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919117044363/doc4.xml","form_type":"4"}},{"id":4260878,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-07-07T16:04:31.000Z","date":"2017-07-06","kind":"sale","acquired":false,"shares":1806,"price":38.84,"value":70145.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units on July 1, 2017. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a \"sell to cover\" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in this Column 4 is a weighted average price. The shares were sold as part of a group sale of shares in multiple transactions at prices ranging from $36.85 to $40.05, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"The reporting person previously reported restricted stock units granted to the reporting person on April 1, 2016 in Table I of the Form 4 filed on April 6, 2016. As such, no adjustment to the reporting person's beneficial interest needs to be made to reflect the vesting event related to this securities sale."}],"balance_after":73030,"source":{"system":"sec-edgar","filing":"0001209191-17-044363","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919117044363/doc4.xml","form_type":"4"}},{"id":4260877,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-07-07T16:04:31.000Z","date":"2017-07-06","kind":"sale","acquired":false,"shares":3569,"price":38.84,"value":138619.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units on June 30, 2017. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a \"sell to cover\" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in this Column 4 is a weighted average price. The shares were sold as part of a group sale of shares in multiple transactions at prices ranging from $36.85 to $40.05, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The reporting person previously reported restricted stock units granted to the reporting person on July 15, 2015 in Table I of the Form 4 filed on July 17, 2015. As such, no adjustment to the reporting person's beneficial interest needs to be made to reflect the vesting event related to this securities sale."}],"balance_after":74836,"source":{"system":"sec-edgar","filing":"0001209191-17-044363","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919117044363/doc4.xml","form_type":"4"}}],"next_cursor":"2017-07-07T16:04:31.000000Z,4260877"}